Citizens National Bank Trust Department’s Pfizer PFE Stock Holding History

Citizens National Bank Trust Department’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Sell	48,004 -290	-0.6%	-$7.59K	0.17%	110
2026 Q1	$1.36M	Buy	48,294 +1,739	+4%	+$46.3K	0.23%	99
2025 Q4	$1.16M	Sell	46,555 -2,910	-6%	-$73.4K	0.2%	106
2025 Q3	$1.26M	Buy	49,465 +3,362	+7%	+$83K	0.22%	102
2025 Q2	$1.12M	Buy	46,103 +395	+0.9%	+$9.21K	0.22%	104
2025 Q1	$1.16M	Sell	45,708 -730	-2%	-$19.1K	0.25%	100
2024 Q4	$1.23M	Sell	46,438 -6,331	-12%	-$172K	0.26%	90
2024 Q3	$1.53M	Buy	52,769 +5,355	+11%	+$156K	0.32%	82
2024 Q2	$1.33M	Sell	47,414 -1,950	-4%	-$53.7K	0.3%	85
2024 Q1	$1.37M	Sell	49,364 -2,551	-5%	-$70.8K	0.32%	83
2023 Q4	$1.49M	Sell	51,915 -3,725	-7%	-$113K	0.38%	72
2023 Q3	$1.85M	Buy	55,640 +190	+0.3%	+$6.72K	0.51%	62
2023 Q2	$2.03M	Buy	55,450 +13,724	+33%	+$534K	0.54%	59
2023 Q1	$1.7M	Sell	41,726 -350	-0.8%	-$15.1K	0.47%	67
2022 Q4	$2.16M	Sell	42,076 -250	-0.6%	-$12K	0.61%	57
2022 Q3	$1.85M	Sell	42,326 -1,400	-3%	-$68K	0.57%	59
2022 Q2	$2.29M	Buy	43,726 +21,175	+94%	+$1.08M	0.66%	53
2022 Q1	$1.11M	Sell	22,551 -300	-1%	-$15.6K	0.45%	67
2021 Q4	$1.35M	Sell	22,851 -28,918	-56%	-$1.43M	0.51%	63
2021 Q3	$2.23M	Sell	51,769 -7,500	-13%	-$332K	0.63%	56
2021 Q2	$2.32M	Sell	59,269 -4,229	-7%	-$164K	0.66%	53
2021 Q1	$2.3M	Sell	63,498 -850	-1%	-$30.2K	0.7%	48
2020 Q4	$2.37M	Sell	64,348 -3,633	-5%	-$133K	0.78%	45
2020 Q3	$2.37M	Buy	67,981 +3,215	+5%	+$113K	0.92%	42
2020 Q2	$2.01M	Hold	64,766	–	–	0.86%	45
2020 Q1	$2.01M	Buy	+64,766	New	+$2.21M	1.07%	38

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citizens National Bank Trust Department's PFE Position: Q2 2026 in Review

Citizens National Bank Trust Department reduced its Pfizer (PFE) stake by 0.6% in Q2 2026, selling an estimated $7.59K and leaving 48,004 shares worth $1.16M. The position accounts for 0.17% of the portfolio, ranked #110.

Citizens National Bank Trust Department first reported a position in PFE in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.37M in Q4 2020. 2,824 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Citizens National Bank Trust Department held 48,004 shares of Pfizer worth $1.16M as of Q2 2026.
Citizens National Bank Trust Department sold 290 Pfizer shares in Q2 2026, an estimated $7.59K.
Pfizer made up 0.17% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #110 holding.
Citizens National Bank Trust Department first reported a position in Pfizer in Q1 2020 and has held it in 26 quarters since.
Citizens National Bank Trust Department's Pfizer position peaked at $2.37M in Q4 2020.
2,824 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.